Risk of hospitalization among patients with co-occurring psychotic and substance use disorders: A 12-year follow-up;Il rischio di ricovero in pazienti comorbili affetti da disturbi psicotici e da uso di sostanze: Follow-up a 12 anni

Rivista di Psichiatria

Volumn 48, Issue 1, 2013, Pages 51-59

  Bartoli, Francesco ^a   Scarone, Silvio ^b   Clerici, Massimo ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Comorbidity; Hospitalization; Psychosis; Substance use disorder

Indexed keywords

ADDICTION SEVERITY INDEX; ARTICLE; COMORBIDITY; DISEASE ASSOCIATION; FOLLOW UP; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; OUTPATIENT; PROGNOSIS; PSYCHOSIS; QUESTIONNAIRE; RETROSPECTIVE STUDY; RISK FACTOR; SUBSTANCE ABUSE; ADDICTION; ADULT; FEMALE; MALE; STATISTICS; TIME;

ADULT; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; MALE; PSYCHOTIC DISORDERS; RISK FACTORS; SUBSTANCE-RELATED DISORDERS; TIME FACTORS;

MLCS; MLOWN;

EID: 84875584321     PISSN: 00356484     EISSN: 20382502     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Carrà G, Johnson S. Variations in rates of comorbid substance use in psychosis between geographical areas and mental health settings in the UK. Soc Psychiatry Psychiatr Epidemiol 2009; 44: 429-47.
2. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990; 264: 2511-8.
3. Kessler RC, Nelson CB, McGonagle KA, Edlund MJ, Frank RG, Leaf PJ. The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatry 1996; 66: 17-31.
4. Carrà G, Johnson S, Bebbington P, et al. The lifetime and pastyear prevalence of dual diagnosis in people with schizophrenia across Europe: findings from the European Schizophrenia Cohort (EuroSC). Eur Arch Psychiatry Clin Neurosci 2012; 262: 607-16.
5. Alonso J, Angermeyer MC, Bernert S, et al. Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004; 420: 21-7.
6. Alonso J, Angermeyer MC, Bernert S, et al. 12-month comorbidity patterns and associated factors in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004; 420: 28-37.
7. Carrà G, Sciarini P, Borrelli P, et al. Dual Diagnosis in Italy: findings from the Psychiatric and Addictive Dual Diagnosis in Italy (PADDI) Study. Dip Patol 2010; 1: 9-16.
8. Drake RE, Alterman AI, Rosenberg SR. Detection of substance use disorders in severely mentally ill patients. Community Ment Health J 1993; 29: 175-92.
9. Clerici M, Carta I. Personality disorders among psychoactive substance users: diagnostic and psychodynamic issues. Eur Addict Res 1996; 2: 147-55.
10. Pozzi G, Bacigalupi M, Tempesta E. Comorbidity of drug dependence and other mental disorders: a two-phase study of prevalence at outpatient treatment centres in Italy. Drug Alcohol Depend 1997; 46: 69-77.
11. Margolese HC, Negrete JC, Tempier R, Gill K. 12-month prospective follow-up study of patients with schizophrenia-spectrum disorders and substance abuse: changes in psychiatric symptoms and substance use. Schizophr Res 2006; 83: 65-75.
12. Hunt GE, Bergen J, Bashir M. Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse. Schizophr Res 2002; 54: 253-64.
13. Malla A, Norman R, Bechard-Evans L, Schmitz N, Manchanda R, Cassidy C. Factors influencing relapse during a 2-year followup of first-episode psychosis in a specialized early intervention service. Psychol Med 2008; 38: 1585-93.
14. Talamo A, Centorrino F, Tondo L, Dimitri A, Hennen J, Baldessarini RJ. Comorbid substance-use in schizophrenia: relation to positive and negative symptoms. Schizophr Res 2006; 86: 251-5.
15. Margolese HC, Malchy L, Negrete JC, Tempier R, Gill K. Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences. Schizophr Res 2004; 67: 157-66.
16. Lagerberg TV, Andreassen OA, Ringen PA, et al. Excessive substance use in bipolar disorder is associated with impaired functioning rather than clinical characteristics, a descriptive study. BMC Psychiatry 2010; 10: 9.
17. Rush B, Koegl CJ. Prevalence and profile of people with co-occurring mental and substance use disorders within a comprehensive mental health system. Can J Psychiatry 2008; 53: 810-21.
18. Fazel S, Lichtenstein P, Grann M, Goodwin GM, Långström N. Bipolar disorder and violent crime: new evidence from population-based longitudinal studies and systematic review. Arch Gen Psychiatry 2010; 67: 931-8.
19. Fazel S, Långström N, Hjern A, Grann M, Lichtenstein P. Schizophrenia, substance abuse, and violent crime. JAMA 2009; 301: 2016-23.
20. Elbogen EB, Johnson SC. The intricate link between violence and mental disorder. results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2009; 66: 152-61.
21. Amore M, Menchetti M, Tonti C, et al. Predictors of violent behavior among acute psychiatric patients: clinical study. Psychiatry Clin Neurosci 2008; 62: 247-55.
22. Cantwell R; Scottish Comorbidity Study Group. Substance use and schizophrenia: effects on symptoms, social functioning and service use. Br J Psychiatry 2003; 182: 324-9.
23. Zimmerman M, Galione JN, Chelminski I, Young D, Dalrymple K, Ruggero CJ. Sustained unemployment in psychiatric outpatients with bipolar disorder: frequency and association with demographic variables and comorbid disorders. Bipolar Disord 2010; 12: 720-6.
24. Wade D, Harrigan S, Edwards J, Burges PM, Whelan G, McGorry PD. Substance misuse in first episode psychosis: 15 month prospective follow-up study. Br J Psychiatry 2006; 189: 229-34.
25. Opsal A, Clausen T, Kristensen O, Elvik I, Joa I, Larsen TK. Involuntary hospitalization of first-episode psychosis with substance abuse during a 2-year follow-up. Acta Psychiatr Scand 2011; 124: 198-204.
26. Farris C, Brems C, Johnson ME, Wells R, Burns R, Kletti N. A comparison of schizophrenic patients with or without coexisting substance use disorder. Psychiatr Q 2003; 74: 205-22.
27. Prince JD, Akincigil A, Hoover DR, Walkup JT, Bilder S, Crystal S. Substance abuse and hospitalization for mood disorder among Medicaid beneficiaries. Am J Public Health 2009; 99: 160-7.
28. Gerding LB, Labbate LA, Measom MO, Santos AB, Arana GW. Alcohol dependence and hospitalization in schizophrenia. Schizophr Res 1999; 38: 71-5.
29. Miles H, Johnson S, Amponsah-Afuwape S, Finch E, Leese M, Thornicroft G. Characteristics of subgroups of individuals with psychotic illness and a comorbid substance use disorder. Psychiatr Serv 2003; 54: 554-61.
30. Leamon MH, Gibson DR, Canning RD, Benjamin L. Hospitalization of patients with cocaine and amphetamine use disorders from a psychiatric emergency service. Psychiatr Serv 2002; 53: 1461-6.
31. Ries RK, Russo J, Wingerson D, et al. Shorter hospital stays and more rapid improvement among patients with schizophrenia and substance disorders. Psychiatr Serv 2000; 51: 210-5.
32. Schmidt LM, Hesse M, Lykke J. The impact of substance use disorders on the course of schizophrenia-a 15-year follow-up study: dual diagnosis over 15 years. Schizophr Res 2011; 130: 228-33.
33. American Psychiatric Association. DSM-IV Diagnostic and Statistical Manual of Mental Disorders. Washington DC: American Psychiatric Association, 1994.
34. McLellan AT, Luborsky L, Woody GE, O'Brien CP. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis 1980; 168: 26-33.
35. Kroken RA, Johnsen E, Ruud T, Wentzel-Larsen T, Jørgensen HA. Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study. BMC Psychiatry 2009; 9: 24.
36. Atkins M, Burgess A, Bottomley C, Riccio M. Chlorpromazine equivalents: a consensus of opinion for both clinical and research applications. Psychiatr Bull 1997; 21: 224-6.
37. Large MM, Smith G, Sara G, Paton MB, Kedzior KK, Nielssen OB. Meta-analysis of self-reported substance use compared with laboratory substance assay in general adult mental health settings. Int J Methods Psychiatr Res 2012; 21: 134-48.
38. Drake RE, McHugo GJ, Xie H, Fox M, Packard J, Helmstetter B. Ten-year recovery outcomes for clients with co-occurring schizophrenia and substance use disorders. Schizophr Bull 2006; 32: 464-73.
39. Xie H, McHugo GJ, Helmstetter BS, Drake RE. Three-year recovery outcomes for long-term patients with co-occurring schizophrenic and substance use disorders. Schizophr Res 2005; 75: 337-48.